Original paperImmunotherapyDifferential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells

Luciano Castiello,Miriam Mossoba, Antonella Viterbo,Marianna Sabatino,Vicki Fellowes,Jason E. Foley,Matthew Winterton,David C. Halverson,Sara Civini,Ping Jin,Daniel H. Fowler,David F. Stroncek

Cytotherapy（2013）

引用 0|浏览14

暂无评分

摘要

Background aims\r\nWe completed a phase II clinical trial evaluating rapamycin-resistant allogeneic T cells (T-rapa) and now have evaluated a T-rapa product manufactured in 6 days (T-rapa6) rather than 12 days (T-Rapa12).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要